New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 20, 2014
10:00 EDTTLM, GTE, MTX, SVA, YUM, WCG, ULTA, NRG, VOYA, CX, JBL, TRNX, IPHI, EE, AMH, WEX, ASGN, INFN, HELI, MACOn The Fly: Analyst Upgrade Summary
American Homes 4 Rent (AMH) upgraded to Buy from Neutral at BofA/Merrill... CEMEX (CX) upgraded to Buy from Neutral at Longbow... CHC Group (HELI) upgraded to Overweight from Neutral at JPMorgan... El Paso Electric (EE) upgraded to Neutral from Sell at Goldman... ING U.S. (VOYA) upgraded to Buy from Hold at Deutsche Bank... Infinera (INFN) upgraded to Buy from Hold at Stifel... Inphi (IPHI) upgraded to Buy from Hold at Stifel... NRG Energy (NRG) upgraded to Conviction Buy from Neutral at Goldman... On Assignment (ASGN) upgraded to Outperform from Market Perform at Wells Fargo... Tornier (TRNX) upgraded to Outperform from Market Perform at Wells Fargo... Ulta Salon (ULTA) upgraded to Buy from Neutral at Goldman... WEX Inc. (WEX) upgraded to Buy from Neutral at Citigroup... Jabil Circuit (JBL) upgraded to Sector Perform from Underperform at Scotia Capital... Macerich (MAC) upgraded to Buy from Hold at Sandler O'Neill... Sinovac Biotech (SVA) upgraded at Morgan Stanley... Gran Tierra (GTE) upgraded to Buy from Hold at TD Securities... WellCare (WCG) upgraded to Outperform from Market Perform at Leerink... Minerals Technologies (MTX) upgraded to Overweight at First Analysis... Talisman Energy (TLM) upgraded to Buy from Hold at TD Securities... Yum! Brands (YUM) upgraded to Outperform from Market Perform at First Global.
News For AMH;CX;HELI;EE;VOYA;INFN;IPHI;NRG;ASGN;TRNX;ULTA;WEX;JBL;MAC;SVA;GTE;WCG;MTX;TLM;YUM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
February 23, 2015
16:27 EDTWCGOn The Fly: Closing Wrap
Stocks on Wall Street began the session in negative territory and remained there for most of the session, with the Nasdaq the lone index to post a small gain. The Dow was weighed down by shares of Boeing (BA), which slid after the stock received a downgrade. There was little in the way of positive economic news, as the most notable report showed existing homes were lower than expected due to a shortage of inventory. The averages drifted for most of the session, as investors may be waiting on the sidelines ahead of tomorrow’s banking panel testimony by Fed Chair Janet Yellen. ECONOMIC EVENTS: In the U.S., the Chicago Fed national activity index rebounded to 0.13 in January, which was nearly in-line with expectations. Existing home sales dropped 4.9% to a 4.82M rate in January, which was much worse than the expected 1.8% drop to a 4.95M unit rate. In Europe, the Ifo Institute’s measure of German business confidence rose to 106.8 in February, which was up a tenth of a percentage point from the previous month but below the 107.7 consensus forecast. Also, the Bank of Israel became the latest central bank to cut rates this year, lowering its main interest rate to 0.1% from 0.25%. COMPANY NEWS: The shares of a number of health insurers rose after the Centers for Medicare and Medicaid Services, or CMS, issued preliminary 2016 Medicare Advantage rates. According to Credit Suisse, the rates were favorable for the insurers. Following the CMS announcement made late Friday, Humana (HUM) climbed $8.40, or 5.38%, to $164.52, UnitedHealth (UNH) rose $3.78, or 3.36%, to $116.40, and WellCare (WCG) gained $4.68, or 5.53%, to $89.30. MAJOR MOVERS: Among the notable gainers was PTC Therapeutics (PTCT), which jumped $9.77, or 17.7%, to $64.96 after Reuters said the company is working with financial advisers to explore a potential sale after receiving takeover interest from several companies including Shire (SHPG) and BioMarin (BMRN). Also higher was Valeant (VRX), which rose $25.49, or 14.71%, to $198.75 after the company agreed to buy Salix (SLXP) for $158 per share and also reported better-than-forecast earnings. Salix shares, however, fell $2.09, or 1.32%, to $155.76, as a report Friday from CNBC's David Faber telegraphed the deal and suggested Valeant could value Salix around $160 per share. Among the noteworthy losers was Spectrum Pharmaceuticals (SPPI), which dropped $1.18, or 15.82%, to $6.28 after a judge ruled that a drug which could compete with the company's Fusilev treatment does not infringe on the company's intellectual property. Also lower were shares of Boeing, which fell $3.57, or 2.26%, to $154.74 after the stock was downgraded to Sell from Neutral at Goldman Sachs. INDEXES: The Dow fell 23.60, or 0.13%, to 18,116.84, the Nasdaq gained 5.01, or 0.1%, to 4,960.97, and the S&P 500 slipped 0.64, or 0.03%, to 2,109.66.
12:21 EDTWCGOn The Fly: Midday Wrap
Subscribe for More Information
11:10 EDTWCGHealth insurers rise after CMS releases preliminary Medicare Advantage rates
The shares of a number of health insurers are rising after the Centers for Medicare and Medicaid Services, or CMS, issued preliminary 2016 Medicare Advantage rates. According to Credit Suisse, the rates were favorable for health insurers. WHAT'S NEW: On Friday after the market closed, CMS issued a proposal for 2016 Medicare Advantage rates. The rates are preliminary and could change when CMS announces the final 2016 rates on April 6 of this year, the agency noted. In a note to investors earlier today, Credit Suisse analyst Ralph Giacobbe estimated that, under CMS' initial proposal, insurers would see rate changes of between -1% and +1%, depending on the risk that each insurer faces. The preliminary rates were "favorable" for insurers, since the rates were "in-line if not slightly better" than investors had expected, the firm stated. Moreover, CMS decided not to restrict at-home health risk assessments, as had been feared, and agreed to reduce the weighting of certain risk factors that had hurt previously certain plans with a higher proportion of low-income beneficiaries, acceding to a request by insurers. Insurers with the highest exposure to Medicare Advantage include Humana (HUM), UnitedHealth (UNH), and WellCare (WCG), the analyst stated. WHAT'S NOTABLE: After analyzing CMS' proposal, health insurer Aetna (AET) estimated that the proposal would cause government funding for its Medicare Advantage business to decline by about 1% in 2016. Aetna added that it is continuing to evaluate the changes outlined in the Advance Notice and their impact on the company and its Medicare Advantage members. OTHERS TO WATCH: Other publicly traded health insurance companies include Anthem (ANTM), AMERIGROUP (AGP), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), and Molina Healthcare (MOH). PRICE ACTION: In mid-morning trading, Humana climbed 5.3% to $164.43, UnitedHealth rose 2.6% to $115.56, WellCare gained 6.3% to $90, Aetna advanced 2% to $99.91, and Centene added 3.4% to $61.93.
10:17 EDTTLMOptions with decreasing implied volatility
Subscribe for More Information
08:05 EDTWCGCMS releases preliminary Medicare Advantage rates for 2016
Subscribe for More Information
February 20, 2015
12:46 EDTTLMTalisman Energy receives final court approval for acquisition by Repsol
Subscribe for More Information
10:49 EDTTLMOptions with increasing implied volatility: LO TLM
Subscribe for More Information
February 19, 2015
08:38 EDTCXPattern Energy signs joint ventuer with CEMEX Energia
Subscribe for More Information
08:38 EDTCXCEMEX creates Mexican energy division, signs joint venture with Pattern
Subscribe for More Information
February 18, 2015
16:26 EDTASGNOn Assignment sees Q1 adjusted EPS 41c-44c, consensus 44c
Sees Q1 revenue $432M-$439M, consensus $461.7M. The revenues estimates include approximately $2.5M-$3.5M for the adverse effect of the inclement weather in the first quarter. The above estimates also include the effects of the payroll tax reset, which occurs at the beginning of every year. This reset results in an estimated sequential increase in cost of sales of $4.0M-$4.5M and a sequential increase in SG&A expenses of approximately $3M.
16:24 EDTASGNOn Assignment reports Q4 adjusted EPS 60c, consensus 53c
Reports Q4 revenue $475.8M, consensus $472.8M.
13:28 EDTTLMTalisman Energy receives shareholder approval for acquisition by Repsol
Subscribe for More Information
10:42 EDTTLMOptions with increasing implied volatility: NLNK TLM
Subscribe for More Information
10:08 EDTTLMTalisman Energy to host special shareholder meeting
Subscribe for More Information
08:21 EDTWCGWellCare price target raised to $105 from $95 at Leerink
Subscribe for More Information
07:29 EDTWCGWellCare management team has improved, says Stifel
Subscribe for More Information
06:56 EDTWCGObamacare enrollment exceeded goal, Politico reports
Subscribe for More Information
February 17, 2015
18:06 EDTTLMPaulson & Co gives quarterly update on stakes
Subscribe for More Information
17:13 EDTTLMPoint72 gives quarterly update on stakes
Subscribe for More Information
06:50 EDTASGNOn Assignment price target raised to $45 from $35 at Piper Jaffray
Piper Jaffray raised its price target for On Assignment shares to $45 saying temporary staffing demand is improving. It sees positive catalysts for the stock and keeps an Overweight rating on the name.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use